TRANSCODE THERAPEUTICS, INC. Retained Earnings
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Retained Earnings of -$122.40 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$122.40M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$115.65M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$97.86M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$84.42M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$122.40M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$115.65M 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$97.86M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$84.42M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$79.56M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$75.29M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$63.20M 10-K · filed 2026-04-15 |
| 2024-09-30 | -$57.26M 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$54.93M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$49.74M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$46.42M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$42.33M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$37.03M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$32.69M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$27.87M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$22.74M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$18.45M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$13.78M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$10.31M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$7.51M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$5.18M 10-Q · filed 2021-08-23 |
| 2020-12-31 | -$3.46M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |